Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Methylprednisolone Acetate Patent Expiration

Methylprednisolone Acetate was first introduced by Pfizer Inc in its drug Depo-Medrol on Approved Prior to Jan 1, 1982. Other drugs containing Methylprednisolone Acetate are Medrol Acetate, Medrol. 14 different companies have introduced drugs containing Methylprednisolone Acetate.


About Veterinary Methylprednisolone Acetate

Methylprednisolone Acetate is used in drugs marketed by 2 different companies: Zoetis Inc, Cronus Pharma Specialities India Private Ltd.

Other drugs containing Methylprednisolone Acetate are: Depo medrol , Methylprednisolone acetate inj. .

Methylprednisolone Acetate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Methylprednisolone Acetate Generic API Manufacturers

Several generic applications have been filed for Methylprednisolone Acetate. The first generic version for Methylprednisolone Acetate was by Watson Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Hikma Pharmaceuticals Usa Inc and was approved on Apr 16, 2025.

Given below is the list of companies who have filed for Methylprednisolone Acetate generic, along with the locations of their manufacturing plants worldwide.